Markets are Closed
Company Logo
BIO
Bio-Rad Laboratories Inc. Class A

Open

Previous Open

High

573.49

Previous High

Low

554.07

Previous Low

Close

554.98

Previous Close

Volume

249,139

Previous Volume

Company Profile

Description

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.

Exchange

New York Stock Exchange

List Date

January 02, 1990

CEO

Norman Schwartz

Employees

8,150

Financials

Revenue

2.31B

Earnings

2.28B
2B
1B
1B
672M
57M
2015
2016
2017
2018

Splits

March 08, 20020.50%

Dividends

No dividends paid to date

Related News

News post image: Bio-Rad, Biodesix Partner to Get EUA for Coronavirus Test
Bio-Rad, Biodesix Partner to Get EUA for Coronavirus Test
Mar 23, 2020 @ 15:16
Bio-Rad (BIO) inks partnership deal with Biodesix to receive a EUA for a ddPCR test....
finance yahoo
News post image: Bio-Rad's ddPCR System Detects Coronavirus More Accurately
Bio-Rad's ddPCR System Detects Coronavirus More Accurately
Mar 20, 2020 @ 14:43
Bio-Rad's (BIO) ddPCR System shows better sensitivity and precision in the detection of SARS-CoV-2, unlike existing qPCR tests....
finance yahoo
News post image: Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR™ Test to the U.S.
Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR™ Test to the U.S.
Mar 20, 2020 @ 11:00
Biodesix, Inc., a leading diagnostic company in lung disease, today announced a partnership with Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) to bring a COVID-19 Droplet Digital PCR (ddPCR) test to the FDA for an Emergency Use Authorization (EUA) approval to support the escalating need for testing...
finance yahoo
News post image: New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests
New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests
Mar 19, 2020 @ 21:30
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies published this month, ahead of peer-review, researchers in China reported that Bio-Rad’s QX200 Droplet Digital PCR (ddPCR) System showed superior...
finance yahoo
News post image: Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing
Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing
Mar 18, 2020 @ 23:24
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its Real-Time qPCR products are being used by testing laboratories globally to screen for COVID-19....
finance yahoo
News post image: Hedge Funds Have Never Been More Bullish On Bio-Rad Laboratories, Inc. (BIO)
Hedge Funds Have Never Been More Bullish On Bio-Rad Laboratories, Inc. (BIO)
Mar 17, 2020 @ 15:27
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
finance yahoo
News post image: Why Is Bio-Rad (BIO) Down 8.3% Since Last Earnings Report?
Why Is Bio-Rad (BIO) Down 8.3% Since Last Earnings Report?
Mar 14, 2020 @ 15:30
Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
finance yahoo
News post image: Bio-Rad Launches SARS CoV-2 Standard for Coronavirus Testing
Bio-Rad Launches SARS CoV-2 Standard for Coronavirus Testing
Mar 13, 2020 @ 13:45
With the launch of Bio-Rad's (BIO) SARS CoV-2 Standard, it aims to help laboratories validate coronavirus testing and accelerate the access to testing....
finance yahoo
News post image: Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing
Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing
Mar 12, 2020 @ 23:30
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that through its Exact Diagnostics product line Bio-Rad has launched a SARS CoV-2 Standard to support laboratory assay validation of coronavirus (COVID-19) testing...
finance yahoo
News post image: With EPS Growth And More, Bio-Rad Laboratories (NYSE:BIO) Is Interesting
With EPS Growth And More, Bio-Rad Laboratories (NYSE:BIO) Is Interesting
Mar 09, 2020 @ 12:34
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story......
finance yahoo